Company News For Oct 11, 2017

Zacks Equity Research Published on October 11, 2017

Shares Barracuda Networks, Inc. gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million
Merck & Co., Inc.’s (MRK - Free Report) shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. (KALV - Free Report) at a price of $8.50 per share
AnaptysBio, Inc.’s (ANAB - Free Report) shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis
Shares of Hudson Technologies Inc. (HDSN - Free Report) declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.